Home > Cardiology > HFA 2024 > HFA 2024 Highlights Podcast

HFA 2024 Highlights Podcast

Presented by
Dr Rachel Giles, Medicom
HFA 2024

Welcome to this podcast (18:23) brought to you by Medicom Medical Publishers about the cutting-edge science in heart failure management presented at the Heart Failure Association (HFA) 2024, a scientific congress of the European Society of Cardiology (ESC). The meeting took place 11-14 May at the Lisbon Congress Centre in Portugal and online.

Heart Failure is a life-threatening syndrome affecting more than 64 million people worldwide. Up to one-third of patients die within 1 year of hospital admission and 50-75% die within 5 years of admission. With such an important topic, what updates did we see at HFA 2024? In addition to several selected summaries of talks, we have an exclusive Meet-the-Trialist interview with Dr Jasper Brugts (Erasmus University Medical Center, Rotterdam, the Netherlands), about the late-breaking MONITOR-HF trial.

In this podcast, we cover:

  1. SEQUOIA-HCM: Aficamten demonstrates clinical efficacy in obstructive HCM
  2. The phase 2 MIRACLE trial in HF + CKD
  3. The T2D subanalysis for EMPACT-MI trial; for an exclusive interview with the Prof Javed Butler, listen here.
  4. SGLT2 inhibitors decrease atrial fibrillation risk in HFrEF patients
  5. Interview with Dr Brugts on MONITOR-HF.
Enjoy listening!

Posted on